- Patent Title: 1-cyclopropyl-7-(4-((5-(3,5-dichlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic aci d as an anti-inflammatory compound
-
Application No.: US18377139Application Date: 2023-10-05
-
Publication No.: US11891385B1Publication Date: 2024-02-06
- Inventor: Mai Mostafa Khalaf Ali , Hany Mohamed Abd El-Lateef Ahmed , Antar Ahmed Abdelhamid Ahmed , Amer A. Amer
- Applicant: KING FAISAL UNIVERSITY
- Applicant Address: SA Al-Ahsa
- Assignee: KING FAISAL UNIVERSITY
- Current Assignee: KING FAISAL UNIVERSITY
- Current Assignee Address: SA Al-Ahsa
- Agency: Nath, Goldberg & Meyer
- Agent Richard C. Litman
- Main IPC: C07D417/12
- IPC: C07D417/12 ; A61P29/00
Abstract:
A 1-cyclopropyl-7-(4-((5-(4-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound, its synthesis, and its use as an anti-inflammation agent.
Information query
